Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 350.60
+8.60 (2.51%)
At close: Mar 20, 2026
Novozymes Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 583.6 | 305.8 | 405.9 | 494.2 | 423.12 |
Depreciation & Amortization | 574.8 | 544.1 | 186.4 | 182.7 | 171.75 |
Other Amortization | - | - | - | 13.18 | 13.05 |
Loss (Gain) From Sale of Assets | - | - | - | -39.26 | -20.04 |
Asset Writedown & Restructuring Costs | - | - | - | 3.76 | 5.65 |
Loss (Gain) From Sale of Investments | - | - | - | -33.34 | 0.4 |
Loss (Gain) on Equity Investments | - | - | - | 0.94 | 0.54 |
Stock-Based Compensation | - | - | - | 17.07 | 10.49 |
Provision & Write-off of Bad Debts | - | - | - | 2.02 | -1.88 |
Other Operating Activities | 7.1 | -101 | -12.1 | -23.12 | 26.63 |
Change in Accounts Receivable | - | - | - | -44.37 | -77.2 |
Change in Inventory | 63.8 | 183.9 | - | -105.8 | -74.78 |
Change in Accounts Payable | - | - | - | 71.79 | 69.67 |
Change in Other Net Operating Assets | -7.8 | 87.1 | -23.1 | -1.21 | -1.08 |
Operating Cash Flow | 1,222 | 1,020 | 557.1 | 538.57 | 546.32 |
Operating Cash Flow Growth | 19.77% | 83.07% | 3.44% | -1.42% | -6.63% |
Capital Expenditures | -409.8 | -338.3 | -249.1 | -371.05 | -144.04 |
Sale of Property, Plant & Equipment | 19.7 | 0.8 | 0.5 | 3.76 | 16.68 |
Cash Acquisitions | -1,520 | 14.8 | -22.7 | -10.35 | -219.36 |
Divestitures | - | 144.5 | 11.8 | 35.9 | - |
Sale (Purchase) of Intangibles | -61 | -21.5 | -26.7 | -17.48 | -22.73 |
Investing Cash Flow | -1,971 | -199.7 | -286.2 | -359.22 | -369.46 |
Short-Term Debt Issued | - | - | - | 25.95 | 42.1 |
Long-Term Debt Issued | 1,717 | 134.5 | 442 | 287.7 | 288.36 |
Total Debt Issued | 1,717 | 134.5 | 442 | 313.65 | 330.45 |
Long-Term Debt Repaid | -504.6 | -539.8 | -334.7 | -231.51 | -186.41 |
Total Debt Repaid | -504.6 | -539.8 | -334.7 | -231.51 | -186.41 |
Net Debt Issued (Repaid) | 1,212 | -405.3 | 107.3 | 82.14 | 144.04 |
Issuance of Common Stock | 44 | 37.8 | 22.4 | 22.05 | 41.56 |
Repurchase of Common Stock | -99.9 | - | - | -67.22 | -201.74 |
Common Dividends Paid | -402.7 | -249.7 | -379 | -204.89 | -197.03 |
Other Financing Activities | - | -86 | -4.2 | -0.13 | -0.13 |
Financing Cash Flow | 753.3 | -703.2 | -253.5 | -168.05 | -213.31 |
Foreign Exchange Rate Adjustments | -8.6 | 13.3 | -7.4 | -0.81 | 7.13 |
Net Cash Flow | -4.7 | 130.3 | 10 | 10.49 | -29.32 |
Free Cash Flow | 811.7 | 681.6 | 308 | 167.51 | 402.27 |
Free Cash Flow Growth | 19.09% | 121.30% | 83.87% | -58.36% | -15.92% |
Free Cash Flow Margin | 19.52% | 17.78% | 12.82% | 7.10% | 20.00% |
Free Cash Flow Per Share | 1.74 | 2.45 | 1.11 | 0.60 | 1.44 |
Cash Interest Paid | 66.4 | 76 | - | 17.61 | 6.99 |
Cash Income Tax Paid | 185.4 | 300.2 | 106 | 122.34 | 84.33 |
Levered Free Cash Flow | 771.78 | 464.96 | 283.34 | 77.29 | 266.03 |
Unlevered Free Cash Flow | 814.46 | 512.71 | 287.4 | 85.86 | 274.6 |
Change in Working Capital | 56 | 271 | -23.1 | -79.59 | -83.39 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.